Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
SLAS Discovery : Advancing Life Sciences R & D|May 23, 2020
Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid NanoparticlesDouglas Ross-Thriepland, Aurelie Bornot, Larissa Butler, et al.
Molecular and Cellular Neurosciences|July 30, 2019
Evoked potentials as a translatable biomarker to track functional remyelinationBrandon J Farley, Elena Morozova, Jessica Dion, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 8, 2020
Developing an Arrayed CRISPR-Cas9 Co-Culture Screen for Immuno-Oncology Target IDSarah Gee, Nadine Nelson, Aurelie Bornot, et al.
ACS Chemical Biology|August 19, 2010
A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cellsDavide Gianni, Nicolas Taulet, Hui Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 9, 2009
Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neuronsPier Paolo Peruzzi, Sean E Lawler, Steve L Senior, et al.
Communications Biology|June 24, 2021
CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cellsAshley J Clark, Niamh Mullooly, Dewi Safitri, et al.
Plos Genetics|April 29, 2021
CRISPR gRNA phenotypic screening in zebrafish reveals pro-regenerative genes in spinal cord injuryMarcus Keatinge, Themistoklis M Tsarouchas, Tahimina Munir, et al.
Human Gene Therapy|November 13, 2012
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1Shilpa Prabhakar, Mehran Taherian, Davide Gianni, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, Laura Breymann, Davide Gianni, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2017
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine KinasesFrank Hilberg, Ulrike Tontsch-Grunt, Anke Baum, et al.
Pageof 6